TY - JOUR
T1 - Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States
AU - Bing, Eric G.
AU - Burnam, M. Audrey
AU - Longshore, Douglas
AU - Fleishman, John A.
AU - Sherbourne, Cathy Donald
AU - London, Andrew S.
AU - Turner, Barbara J.
AU - Eggan, Ferd
AU - Beckman, Robin
AU - Vitiello, Benedetto
AU - Morton, Sally C.
AU - Orlando, Maria
AU - Bozzette, Samuel A.
AU - Ortiz-Barron, Lucila
AU - Shapiro, Martin
PY - 2001
Y1 - 2001
N2 - Background: There have been no previous nationally representative estimates of the prevalence of mental disorders and drug use among adults receiving care for human immunodeficiency virus (HIV) disease in the United States. It is also not known which clinical and sociodemographic factors are associated with these disorders. Subjects and Methods: We enrolled a nationally representative probability sample of 2864 adults receiving care for HIV in the United States in 1996. Participants were administered a brief structured psychiatric instrument that screened for psychiatric disorders (major depression, dysthymia, generalized anxiety disorders, and panic attacks) and drug use during the previous 12 months. Sociodemographic and clinical factors associated with screening positive for any psychiatric disorder and drug dependence were examined in multivariate logistic regression analyses. Results: Nearly half of the sample screened positive for a psychiatric disorder, nearly 40% reported using an illicit drug other than marijuana, and more than 12% screened positive for drug dependence during the previous 12 months. Factors independently associated with screening positive for a psychiatric disorder included number of HIV-related symptoms, illicit drug use, drug dependence, heavy alcohol use, and being unemployed or disabled. Factors independently associated with screening positive for drug dependence included having many HIV-related symptoms, being younger, being heterosexual, having frequent heavy alcohol use, and screening positive for a psychiatric disorder. Conclusions: Many people infected with HIV may also have psychiatric and/or drug dependence disorders. Clinicians may need to actively identify those at risk and work with policymakers to ensure the availability of appropriate care for these treatable disorders.
AB - Background: There have been no previous nationally representative estimates of the prevalence of mental disorders and drug use among adults receiving care for human immunodeficiency virus (HIV) disease in the United States. It is also not known which clinical and sociodemographic factors are associated with these disorders. Subjects and Methods: We enrolled a nationally representative probability sample of 2864 adults receiving care for HIV in the United States in 1996. Participants were administered a brief structured psychiatric instrument that screened for psychiatric disorders (major depression, dysthymia, generalized anxiety disorders, and panic attacks) and drug use during the previous 12 months. Sociodemographic and clinical factors associated with screening positive for any psychiatric disorder and drug dependence were examined in multivariate logistic regression analyses. Results: Nearly half of the sample screened positive for a psychiatric disorder, nearly 40% reported using an illicit drug other than marijuana, and more than 12% screened positive for drug dependence during the previous 12 months. Factors independently associated with screening positive for a psychiatric disorder included number of HIV-related symptoms, illicit drug use, drug dependence, heavy alcohol use, and being unemployed or disabled. Factors independently associated with screening positive for drug dependence included having many HIV-related symptoms, being younger, being heterosexual, having frequent heavy alcohol use, and screening positive for a psychiatric disorder. Conclusions: Many people infected with HIV may also have psychiatric and/or drug dependence disorders. Clinicians may need to actively identify those at risk and work with policymakers to ensure the availability of appropriate care for these treatable disorders.
UR - http://www.scopus.com/inward/record.url?scp=0034890633&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034890633&partnerID=8YFLogxK
U2 - 10.1001/archpsyc.58.8.721
DO - 10.1001/archpsyc.58.8.721
M3 - Article
C2 - 11483137
AN - SCOPUS:0034890633
SN - 0003-990X
VL - 58
SP - 721
EP - 728
JO - Archives of General Psychiatry
JF - Archives of General Psychiatry
IS - 8
ER -